{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:58:41Z","timestamp":1793372321843,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00277-023-05350-y","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T11:02:08Z","timestamp":1689159728000},"page":"2857-2864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease"],"prefix":"10.1007","volume":"102","author":[{"given":"Qing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-2741","authenticated-orcid":false,"given":"Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"5350_CR1","unstructured":"Chinese Center For Disease Control And Prevention. National situation of SARS-CoV-2 infection 2023 [cited 2023]. Available from: https:\/\/www.chinacdc.cn\/jkzt\/crb\/zl\/szkb_11803\/jszl_13141\/202303\/t20230304_264035.html. Accessed 29 Apr 2023"},{"issue":"8","key":"5350_CR2","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41375-020-0876-z","volume":"34","author":"E Terpos","year":"2020","unstructured":"Terpos E, Engelhardt M, Cook G et al (2020) Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia 34(8):2000\u20132011","journal-title":"Leukemia"},{"issue":"12","key":"5350_CR3","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1016\/S2352-3026(21)00278-7","volume":"8","author":"H Ludwig","year":"2021","unstructured":"Ludwig H, Sonneveld P, Facon T et al (2021) COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Haematol 8(12):e934\u2013e946","journal-title":"Lancet Haematol"},{"issue":"3","key":"5350_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1182\/blood.2021012251","volume":"140","author":"P Langerbeins","year":"2022","unstructured":"Langerbeins P, Hallek M (2022) COVID-19 in patients with hematologic malignancy. Blood 140(3):236\u2013252","journal-title":"Blood"},{"issue":"1","key":"5350_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","volume":"14","author":"L Pagano","year":"2021","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F et al (2021) COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol 14(1):168","journal-title":"J Hematol Oncol"},{"issue":"9","key":"5350_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood.2021014989","volume":"139","author":"E Terpos","year":"2022","unstructured":"Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I et al (2022) Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy. Blood 139(9):1409\u20131412","journal-title":"Blood"},{"key":"5350_CR7","unstructured":"World Health Organization. One year since the emergence of COVID-19 virus variant Omicron 2022. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/one-year-since-the-emergence-of-omicron. Accessed 25 Nov 2022"},{"key":"5350_CR8","unstructured":"National Medical Products Administration 2021 Available from: https:\/\/www.nmpa.gov.cn\/zhuanti\/yqyjzxd\/yqyjxd\/20210206154636109.html. Accessed 19 Apr 2023"},{"key":"5350_CR9","unstructured":"National Medical Products Administration 2021 Available from: https:\/\/www.nmpa.gov.cn\/directory\/web\/nmpa\/yaowen\/ypjgyw\/20210225184306142.html. Accessed 19 Apr 2023"},{"key":"5350_CR10","unstructured":"National Comprehensive Cancer Network. Prevention and treatment of cancer-related infections. NCCN Guidelines Version 3.2022. 2022"},{"issue":"4","key":"5350_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11239-020-02174-9","volume":"50","author":"Y Liu","year":"2020","unstructured":"Liu Y, Gao W, Guo W et al (2020) Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. J Thromb Thrombolysis 50(4):825\u2013832","journal-title":"J Thromb Thrombolysis"},{"key":"5350_CR12","unstructured":"World Health Organization. Statement on the fourteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic 2023. Available from: https:\/\/www.who.int\/news\/item\/30-01-2023-statement-on-the-fourteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(COVID-19)-pandemic"},{"key":"5350_CR13","unstructured":"World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic 2023. Available from: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic"},{"issue":"1","key":"5350_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ajh.26762","volume":"98","author":"M Ho","year":"2023","unstructured":"Ho M, Zanwar S, Buadi FK et al (2023 Jan) Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis. Am J Hematol 98(1):49\u201355","journal-title":"Am J Hematol"},{"issue":"2","key":"5350_CR15","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1111\/bjh.16874","volume":"190","author":"G Cook","year":"2020","unstructured":"Cook G, John Ashcroft A, Pratt G et al (2020) Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol 190(2):e83\u2013e86","journal-title":"Br J Haematol"},{"issue":"1","key":"5350_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13045-020-00934-x","volume":"13","author":"B Wang","year":"2020","unstructured":"Wang B, Van Oekelen O, Mouhieddine TH et al (2020) A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. J Hematol Oncol 13(1):94","journal-title":"J Hematol Oncol"},{"issue":"10","key":"5350_CR17","first-page":"103","volume":"10","author":"J Mart\u00ednez-L\u00f3pez","year":"2020","unstructured":"Mart\u00ednez-L\u00f3pez J, Mateos M-V, Encinas C et al (2020) Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality. Blood. Cancer J 10(10):103","journal-title":"Cancer J"},{"issue":"26","key":"5350_CR18","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1182\/blood.2020008150","volume":"136","author":"A Chari","year":"2020","unstructured":"Chari A, Samur MK, Martinez-Lopez J et al (2020) Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood 136(26):3033\u20133040","journal-title":"Blood"},{"issue":"12","key":"5350_CR19","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3324\/haematol.2020.262758","volume":"105","author":"M Engelhardt","year":"2020","unstructured":"Engelhardt M, Shoumariyeh K, R\u00f6sner A et al (2020) Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany. Haematologica 105(12):2872\u20132878","journal-title":"Haematologica"},{"issue":"1","key":"5350_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/jama.2022.21795","volume":"329","author":"A Bilinski","year":"2023","unstructured":"Bilinski A, Thompson K, Emanuel E (2023) COVID-19 and excess all-cause mortality in the US and 20 comparison countries, June 2021-March 2022. JAMA 329(1):92\u201394","journal-title":"JAMA"},{"issue":"1","key":"5350_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/22221751.2022.2060137","volume":"11","author":"PH Cheung","year":"2022","unstructured":"Cheung PH, Chan CP, Jin DY (2022) Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022. Emerg Microbes Infect 11(1):1072\u20131078","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"5350_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41375-023-01920-1","volume":"37","author":"E Terpos","year":"2023","unstructured":"Terpos E, Musto P, Engelhardt M et al (2023) Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia 37(6):1175\u20131185","journal-title":"Leukemia"},{"issue":"2","key":"5350_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1053\/j.seminhematol.2023.03.004","volume":"60","author":"E Terpos","year":"2023","unstructured":"Terpos E, Branagan AR, Garc\u00eda-Sanz R et al (2023) Report of consensus panel 5 from the 11th international workshop on Waldenstrom\u2019s macroglobulinemia on COVID-19 prophylaxis and management. Semin Hematol 60(2):107\u2013112","journal-title":"Semin Hematol"},{"key":"5350_CR24","doi-asserted-by":"publisher","unstructured":"Ashruf OS, Orozco Z, Kaelber DC (2023) Risk and severity of COVID-19 infection in monoclonal gammopathy of undetermined significance: a 3-year propensity matched cohort study. Clin Lymph Myeloma Leukemia. https:\/\/doi.org\/10.1016\/j.clml.2023.04.010","DOI":"10.1016\/j.clml.2023.04.010"},{"issue":"8","key":"5350_CR25","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3390\/cancers15082266","volume":"15","author":"E Liatsou","year":"2023","unstructured":"Liatsou E, Ntanasis-Stathopoulos I, Lykos S et al (2023) Adult patients with cancer have impaired humoral responses to complete and booster COVID-19 vaccination, especially those with hematologic cancer on active treatment: a systematic review and meta-analysis. Cancers 15(8):2266","journal-title":"Cancers"},{"issue":"5","key":"5350_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccell.2022.03.013","volume":"40","author":"A Aleman","year":"2022","unstructured":"Aleman A, Van Oekelen O, Upadhyaya B et al (2022) Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients. Cancer Cell. 40(5):441\u2013443","journal-title":"Cancer Cell."},{"issue":"7","key":"5350_CR27","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00277-022-04799-7","volume":"101","author":"E Hoornaert","year":"2022","unstructured":"Hoornaert E, Dachy F, Hansenne A et al (2022) COVID-19: impact of vaccination in myeloma patients. Ann Hematol 101(7):1607\u20131608","journal-title":"Ann Hematol"},{"key":"5350_CR28","doi-asserted-by":"crossref","unstructured":"Rosati M, Terpos E, Bear J, et al. Low spike antibody levels and impaired BA.4\/5 neutralization in patients with multiple myeloma or Waldenstrom’s macroglobulinemia after BNT162b2 booster vaccination. Cancers 2022;14(23): 5816","DOI":"10.3390\/cancers14235816"},{"issue":"6","key":"5350_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yan LM, Wan L et al (2020 Jun) Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 20(6):656\u2013657","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"5350_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.medcli.2020.12.018","volume":"156","author":"MC Viana-Llamas","year":"2021","unstructured":"Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obreg\u00f3n JA et al (2021) Hypoalbuminemia on admission in COVID-19 infection: an early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc) 156(9):428\u2013436","journal-title":"Med Clin (Barc)"},{"key":"5350_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.2147\/IJGM.S312521","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y, Yang H, Wang J et al (2021) Serum albumin levels are a predictor of COVID-19 patient prognosis: evidence from a single cohort in Chongqing, China. Int J Gen Med 14:2785\u20132797","journal-title":"Int J Gen Med"},{"issue":"1","key":"5350_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/emermed-2020-210081","volume":"39","author":"G Turcato","year":"2022","unstructured":"Turcato G, Zaboli A, Kostic I et al (2022) Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: a multicentre retrospective observational study. Emerg Med J 39(1):63\u201369","journal-title":"Emerg Med J"},{"issue":"14","key":"5350_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2217\/bmm-2022-0364","volume":"16","author":"EO Medina-Hern\u00e1ndez","year":"2022","unstructured":"Medina-Hern\u00e1ndez EO, P\u00e9rez-Navarro LM, Hern\u00e1ndez-Ruiz J et al (2022) Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability. Biomark Med 16(14):1019\u20131028","journal-title":"Biomark Med"},{"issue":"9","key":"5350_CR34","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.ajem.2020.05.073","volume":"38","author":"BM Henry","year":"2020","unstructured":"Henry BM, Aggarwal G, Wong J et al (2020) Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med 38(9):1722\u20131726","journal-title":"Am J Emerg Med"},{"issue":"18","key":"5350_CR35","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1182\/blood.2022017616","volume":"140","author":"M Ho","year":"2022","unstructured":"Ho M, Zanwar S, Buadi FK et al (2022) Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance. Blood 140(18):1997\u20132000","journal-title":"Blood"},{"issue":"8","key":"5350_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41408-021-00530-3","volume":"11","author":"E Terpos","year":"2021","unstructured":"Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I et al (2021) The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment. Blood Cancer J 11(8):138","journal-title":"Blood Cancer J"},{"issue":"8","key":"5350_CR37","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajh.26263","volume":"96","author":"H Ludwig","year":"2021","unstructured":"Ludwig H, San-Miguel J, Munshi N et al (2021) Covid-19 vaccination in patients with multiple myeloma: focus on immune response. Am J Hematol 96(8):896\u2013900","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05350-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:03:46Z","timestamp":1694253826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05350-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5350"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05350-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}